For the year ending 2025-12-31, HRGN made $704K in revenue. -$6,875K in net income. Net profit margin of -976.56%.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Product revenue | 704 | 430 | ||
| Sales and marketing | - | 554 | ||
| Cost of sales | 646 | 270 | ||
| Research and development | 2,653 | 2,310 | ||
| Sales and marketing | 67 | - | ||
| General and administrative | 4,253 | 5,022 | ||
| Total operating expenses | 7,619 | 8,156 | ||
| Operating loss | -6,915 | -7,726 | ||
| Interest income | 37 | 32 | ||
| Interest expense | 8 | 38 | ||
| Other income | 17 | - | ||
| Total other income (expense), net | 46 | -6 | ||
| Net loss | -6,869 | -7,732 | ||
| Foreign currency translation adjustments | -6 | - | ||
| Net loss attributable to common stockholders | - | -7,732 | ||
| Comprehensive loss | -6,875 | - | ||
| Basic EPS | -0.42 | -0.52 | ||
| Basic Average Shares | 16,517,126 | 14,789,332 | ||
Harvard Apparatus Regenerative Technology, Inc. (HRGN)
Harvard Apparatus Regenerative Technology, Inc. (HRGN)